AI Screening for Diabetic Retinopathy

• by Abraham Olvera-Barrios, MD, PhD, Cathy Egan, FRANZCO

• May 1, 2026

Phenotype-driven management of diabetic macular edema: multimodal imaging biomarkers and individualized therapy

• by Zichao You, Li Jiang, Ying-rui Liu, Ming Ming Yang

• June 23, 2026

Semaglutide Linked to NAION Risk

A retrospective database study found a low absolute incidence but higher relative hazard of ischemic optic neuropathy following semaglutide initiation.

• by Andrea Surnit

• May 11, 2026

• 3 min

Advancing Retinal Imaging for Cardiovascular Risk Assessment

• by Federico Bernardo Rossi, Antonio Gallo, Philippe Giral

• May 1, 2026